GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » Winshine Science Co Ltd (HKSE:00209) » Definitions » Forward PE Ratio

Winshine Science Co (HKSE:00209) Forward PE Ratio : 0.00 (As of Jun. 10, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Winshine Science Co Forward PE Ratio?

Winshine Science Co's Forward PE Ratio for today is 0.00.

Winshine Science Co's PE Ratio without NRI for today is 0.00.

Winshine Science Co's PE Ratio for today is 0.00.


Winshine Science Co Forward PE Ratio Historical Data

The historical data trend for Winshine Science Co's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Winshine Science Co Forward PE Ratio Chart

Winshine Science Co Annual Data
Trend
Forward PE Ratio

Winshine Science Co Semi-Annual Data
Forward PE Ratio

Competitive Comparison of Winshine Science Co's Forward PE Ratio

For the Leisure subindustry, Winshine Science Co's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Winshine Science Co's Forward PE Ratio Distribution in the Travel & Leisure Industry

For the Travel & Leisure industry and Consumer Cyclical sector, Winshine Science Co's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Winshine Science Co's Forward PE Ratio falls into.



Winshine Science Co Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Winshine Science Co  (HKSE:00209) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Winshine Science Co Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Winshine Science Co's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Winshine Science Co (HKSE:00209) Business Description

Traded in Other Exchanges
N/A
Address
287-299 Queen's Road, Room 1002, 10th Floor, 299 QRC, Central, Hong Kong, HKG
Winshine Science Co Ltd is an investment holding company. The company's segment includes Securities investments, Toys, and Medical & health. It generates maximum revenue from the Toys segment. The toys segment derives its revenue from manufacturing for the sale of toys. The securities investments segment derives its profits or losses from dividends received from, and other gains or losses from, equity securities investments. The medical and health segment is under the development stage in which research and development expenses for medical and health technology development have been incurred. Its geographical segments are Hong Kong, China, the United States, Europe, and Korea, of which the majority of its revenue comes from the United States.
Executives
Wang Honggang 2101 Beneficial owner
U Credit (hk) Limited 2106 Person having a security interest in shares
Csc Holdings Limited 2106 Person having a security interest in shares
Hurray Talent Investment Development Limited 2101 Beneficial owner
Li Zhonghai 2201 Interest of corporation controlled by you
Liu Lian 2201 Interest of corporation controlled by you
Richsun Investment Development Limited 2101 Beneficial owner
Hong Kong Huiheng Trading And Investment Co., Limited 2101 Beneficial owner
Jiang Qinghui 2201 Interest of corporation controlled by you
Csc Holdings Limited (formerly Known As "china Strategic Holdings Limited") 2106 Person having a security interest in shares
China Strategic Holdings Limited 2106 Person having a security interest in shares
Shen Jia 2101 Beneficial owner

Winshine Science Co (HKSE:00209) Headlines

No Headlines